Company news

AEON Biopharma, Inc. news in 2025

AEON Biopharma, Inc.'s news releases, calls and decks from 2025, newest first.

View company

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

December 15, 2025

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

November 20, 2025

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

November 14, 2025

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data

November 13, 2025

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

October 1, 2025

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

August 12, 2025

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025

May 19, 2025

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 14, 2025

Decks in 2025